Buscar
Mostrando ítems 1-10 de 242
Effects of age on a new animal model of tardive dyskinesia
(Elsevier B.V., 1997-11-01)
The effects of age were studied on a new animal model of tardive dyskinesia, i.e., the quantification of oral dyskinesia in rats repeatedly treated with reserpine. Adult and old rats received two injections of reserpine ...
LACK OF INVOLUNTARY ABNORMAL MOVEMENTS IN UNTREATED SCHIZOPHRENIC-PATIENTS
(EDITORIAL GARSI, 1994)
Drug-naive schizophrenic patients lacked abnormal involuntary movements. Chronic neuroleptic treatment was associated in 4% of the cases with Tardive Dyskinesia (TD). These findings suggest that schizophrenia, at least ...
Reserpine does not induce orofacial dyskinesia in spontaneously hypertensive rats
(Elsevier B.V., 1998-09-04)
The nigrostriatal dopaminergic system seems to be involved in both reserpine-induced orofacial dyskinesia in normal rats and in the pathogenesis of hypertension in spontaneously hypertensive rats. in the present study, ...
Effects of buspirone on an animal model of tardive dyskinesia
(Elsevier B.V., 1999-11-01)
1. the effects of buspirone were studied on an animal model of tardive dyskinesia, i.e., the quantification of orofacial dyskinesia in rats repeatedly treated with reserpine.2. Rats were co-treated with saline [SAL] or ...
Concomitant development of oral dyskinesia and memory deficits in reserpine-treated male and female mice
(Elsevier B.V., 2002-05-14)
It has been suggested that reserpine-induced oral dyskinesia in rats may provide a new animal model of tardive dyskinesia. Both cognitive deficits and gender have been associated with the development of tardive dyskinesia. ...
Open-Access Electronic Diary for Motor Fluctuation and Dyskinesia Evaluation in Parkinson Disease: Comparison with Paper Diary
(Lippincott Williams, 2018-01)
Objective To determine the utility of an electronic diary for registering motor fluctuations and dyskinesia in Parkinson disease (PD). Methods Free, open-access touch screen software suitable for Android 4.4 or higher, ...
NITRIC OXIDE SYNTHASE INHIBITION ATTENUATES L-DOPA-INDUCED DYSKINESIAS IN A RODENT MODEL OF PARKINSON`S DISEASE
(PERGAMON-ELSEVIER SCIENCE LTD, 2009)
Chronic L-DOPA pharmacotherapy in Parkinson`s disease is often, accompanied by the development of abnormal and excessive movements known as L-DOPA-induced dyskinesia. Rats with 6-hydroxydopamine lesion of dopaminergic ...